Hsien-Yen Chang, PhD
Articles
July 19th 2013
Change in Claims-Based Diabetes Medications Is a Diabetes Improvement Indicator
Hsien-Yen Chang, PhD Thomas M. Richards, MS Jeanne M. Clark, MD, MPH Jonathan P. Weiner, DrPH Jodi B. Segal, MD, MPH
Without clinical information, a decrease in use of medications can serve as a proxy for clinical improvement.
November 20th 2012
Validating the Adapted Diabetes Complications Severity Index in Claims Data
Hsien-Yen Chang, PhD Jonathan P. Weiner, DrPH Thomas M. Richards, MSEE Sara N. Bleich, PhD Jodi B. Segal, MD, MPH
The aDCSI without the inclusion of laboratory data performs similarly to the DCSI with laboratory results, and is a good measure of diabetes severity.
April 23rd 2012
Predicting Costs With Diabetes Complications Severity Index in Claims Data
Hsien-Yen Chang, PhD Jonathan P. Weiner, DrPH Thomas M. Richards, MS Sara N. Bleich, PhD Jodi B. Segal, MD, MPH
The Diabetes Complications Severity Index without laboratory test results is a good measure of diabetes severity, given its ability to explain costs.
Latest Updated Articles
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: September 3rd 2024 | Updated: September 10th 2024
PCOC 2024 Promises to Hit All the High Notes
Published: August 30th 2024 | Updated: September 10th 2024
Symptom-Triggered Testing Detects Early-Stage Ovarian Cancer in 1 in 4 Women
Published: August 31st 2024 | Updated: September 10th 2024
Low Patient Involvement in First-Line Ovarian Cancer Treatment Decisions in Europe, US
Published: August 28th 2024 | Updated: September 10th 2024
Illuminating the Future: Dr Kristen Whitney on What's Next for Dermoscopy
Published: August 4th 2024 | Updated: September 10th 2024
Who Should Have Lp(a) Levels Tested? Experts Take Sides
